Evidence map›Paper›PMID 29070611›Full record

ArticleOpen biology2017

Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains.

Yoan R Monneau, Lingjie Luo, Nehru Viji Sankaranarayanan, Balaji Nagarajan, Romain R Vivès, Françoise Baleux, Umesh R Desai, Fernando Arenzana-Seidedos, Hugues Lortat-Jacob

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. The Heparanase Regulatory Network in Health and Disease.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yoan R MonneauUniversity of Grenoble Alpes, CNRS, CEA, IBS, 38000 Grenoble, France.
Lingjie LuoInstitut Pasteur, INSERM U1108, Paris, France.
Nehru Viji SankaranarayananInstitute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.
Balaji NagarajanInstitute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.
Romain R VivèsUniversity of Grenoble Alpes, CNRS, CEA, IBS, 38000 Grenoble, France.
Françoise BaleuxInstitut Pasteur, Unité de Chimie des Biomolécules, UMR CNRS 3523, Paris, France.
Umesh R DesaiInstitute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.
Fernando Arenzana-SeidedosInstitut Pasteur, INSERM U1108, Paris, France.
Hugues Lortat-JacobUniversity of Grenoble Alpes, CNRS, CEA, IBS, 38000 Grenoble, France hugues.lortat-jacob@ibs.fr.ORCID 0000-0002-9772-0762
Centre National de la Recherche Scientifique · FRVirginia Commonwealth University · USInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemokines promote directional cell migration through binding to G-protein-coupled receptors, and as such are involved in a large array of developmental, homeostatic and pathological processes. They also interact with heparan sulfate (HS), the functional consequences of which depend on the respective location of the receptor- and the HS-binding sites, a detail that remains elusive for most chemokines. Here, to set up a biochemical framework to investigate how HS can regulate CXCL13 activity, we solved the solution structure of CXCL13. We showed that it comprises an unusually long and disordered C-terminal domain, appended to a classical chemokine-like structure. Using three independent experimental approaches, we found that it displays a unique association mode to HS, involving two clusters located in the α-helix and the C-terminal domain. Computational approaches were used to analyse the HS sequences preferentially recognized by the protein and gain atomic-level understanding of the CXCL13 dimerization induced upon HS binding. Starting with four sets of 254 HS tetrasaccharides, we identified 25 sequences that bind to CXCL13 monomer, among which a single one bound to CXCL13 dimer with high consistency. Importantly, we found that CXCL13 can be functionally presented to its receptor in a HS-bound form, suggesting that it can promote adhesion-dependent cell migration. Consistently, we designed CXCL13 mutations that preclude interaction with HS without affecting CXCR5-dependent cell signalling, opening the possibility to unambiguously demonstrate the role of HS in the biological function of this chemokine.

Indexed as

Binding SitesMolecular ConformationProtein Interaction Domains and MotifsAmino Acid SequenceChemokine CXCL13Heparan SulfateMagnetic Resonance SpectroscopyModels, MolecularProtein BindingProtein Conformation, alpha-HelicalProtein MultimerizationProtein StabilityRecombinant ProteinsSolutionsStructure-Activity RelationshipChemokine CXCL13Heparan SulfateRecombinant ProteinsSolutionschemokineCXCL13glycosaminoglycanheparan sulfate binding siteheparan sulfate sequence

Identifiers

PMID29070611
PMCPMC5666081
OpenAlexW2765408907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.